Nasacort and Nasonex are both allergy nasal sprays that contain drugs called corticosteroids. With allergies, the body’s immune system responds to an allergen, or trigger. This causes symptoms such as ...

The FDA’s Division of Drug Marketing, Advertising and Communications has issued untitled letters of violation to Schering-Plough for its Nasonex nasal spray, and to GlaxoSmithKline for its Flonase ...

Schering-Plough's successful allergy medication gets an updated ad campaign. The Nasonex Bee is buzzing a new tune. Schering-Plough is working with BBDO to update its successful Nasonex (mometasone ...

With spring allergies in the air, two prescription-products-gone-over-the-counter recently – Astepro and Nasonex -- have sprung creative campaigns. Surrounded by flowers, and clothed and posed as if ...

Mometasone (as furoate monohydrate) 50mcg/spray; contains benzalkonium chloride. Not for treating asthma. Avoid use in patients with recent nasal ulcers, surgery, or injury that has not healed.

Mometasone nasal spray is available as a brand-name drug and a generic drug. Brand name: Nasonex. Mometasone is a corticosteroid that comes in six forms: nasal spray, nasal implant, inhalation powder ...

In an April trial Apotex claimed that its spray differs because it will not contain water, Reuters says. With sales just shy of $1.3 billion in 2011, Nasonex allergy spray is Merck's ...

New York Post may be compensated and/or receive an affiliate commission if you click or buy through our links. Featured pricing is subject to change. April is here, and it feels like everyone (and ...

June 15 (Reuters) - Merck & Co, Inc lost a patent infringement lawsuit against Apotex Inc on Friday over Apotex's plans to market a generic version of the nasal allergy spray Nasonex. Sign up here.

Last week, on Friday, June 15, 2012, Merck (NYSE: MRK) announced the U.S. District Court for the District of New Jersey (Judge Peter G. Sheridan) ruled against the company on the issue of patent ...